Vildagliptin
  • VildagliptinVildagliptin

Vildagliptin

Album crystallinum pulveris Vildagliptin basis est.

Mitte Inquisitionem

depictio producti

Vildagliptin


Vildagliptin CAS: 274901-16-5


Donec Vildagliptin Properties

MF: C17H25N3O2

MW: 303,4

Liquescens punctum, 153-155C

Ferventis punctum: 531,3 ± 50.0 ° C (Praedicta)

Density: 1,27

FP: 275.1â


Vildagliptin Specification:

items

Signa

analyticae results

species

Album crystallinum pulveris

Album crystallinum pulveris

solubility

 

 

 

Facile iure tabescere, methanolum, ethanol, amino sulfoxide, 0.01mol vel aqua / L hydrochloric acid solutionem, leniter aut solutum in acetonitrile isopropanol.

Applica

Lepidium sativum

Silicium identical ut retention of vexillum.

Applica

IR specyrum identical ut a vexillum.

Applica

aqua

â € ¤1.0%

0,21%

Liquescens punctum

148A -152â

149.3-151.4â

Residuum de ignitis

â € ¤0.1%

0,03%

gravis metallis

â € ¤20ppm

ï¼ 20ppm

sulphate

â € ¤0.02%

Applica

chloride

â € ¤0.05%

Applica

Chiral inmunditia

R-isomer impurityâ ¤0.5%

0.01%

 

 

 

 

 

RELICTUM solvent

Ethanolâ ¤5000ppm

318ppm

Acetoneâ ¤5000ppm

33ppm

Acetonitrileâ ¤410ppm

ND

Butyl acetateâ ¤5000ppm

ND

DMFâ ¤880ppm

ND

Ethyl acetateâ ¤5000ppm

ND

Methanolâ ¤3000ppm

ND

Methylene chloride≤600ppm

ND

Yl ethyl ketoneâ ¤5000ppm

ND

Tolueneâ ¤890ppm

ND

Isopropyl Alcoholâ ¤5000ppm

ND

 

Related menstruatae

(Silicium)

Immunditiam BA ¤0.15%

ND

Immunditiam ca ¤0.2%

0,08%

Individual impurityâ € ¤0.1%

0,04%

Total impuritiesâ € ¤1.0%

0,17%

Related menstruatae

ï¼ GCï¼

Immunditiam% AA ¤0.15

ND

silicium primordium

102.0 ï½ 98.0%%

99.6%

particula magnitudine

D90⠤150μ

D90ï¼ 100μ

conclusioni

Applicas withEnterprisestandard.




Hot Tags: Vildagliptin, Manufacturers, Suppliers, Factory, Sinis movere, Assiduo in Sina: Cheap, Discount: price

Related Categoria

Mitte Inquisitionem

Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept